Parth's Starter Pack
Created by
@parthamin.bsky.social
@bloomberg.com
The first word in business news. Newsletters: http://bloom.bg/newsletters Podcasts: http://bloom.bg/podcasts The Big Take podcast: http://trib.al/jtoXfuT
@financialtimes.com
The best of FT journalism, including breaking news and analysis. https://www.ft.com The users this account follows are verified FT staff or contributors.
@jburnmurdoch.ft.com
Columnist and chief data reporter the Financial Times | Stories, stats & scatterplots | john.burn-murdoch@ft.com — On 👨👶 leave until July — 📝 ft.com/jbm
@thesimpletee.bsky.social
Started with love for simplicity & a mission to make tees that speak for themselves—nothing extra, just the perfect words. SHOP NOW -> https://thesimpleteeus.etsy.com/
@erictopol.bsky.social
physician-scientist, author, editor https://www.scripps.edu/faculty/topol/ Ground Truths https://erictopol.substack.com SUPER AGERS https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
@maxroser.bsky.social
— Founder of Our World in Data — Professor at the University of Oxford Data to understand global problems and research to make progress against them.
@carlquintanilla.bsky.social
25+ years at @CNBC and @NBCNews / @WSJ alum / board member, NY City Center
@ourworldindata.org
Research and data to make progress against the world’s largest problems. Based out of Oxford University (@ox.ac.uk), founded by @maxroser.bsky.social.
@byheatherlong.bsky.social
Economic columnist at Washington Post | Data aficionado | Email: Heather.long@washpost.com
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@natureportfolio.nature.com
Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@natashaloder.bsky.social
Health Editor, The Economist. #Science #medicine #health, aspiring optimist, omnivorous information eater, mother of dragons. Free words at: Overmatter.substack.com
@economist.com
News and analysis with a global perspective. We’re here to help you understand the world around you. Subscribe here: https://econ.st/4fAeu4q
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@alleninstitute.org
The Allen Institute is committed to solving mysteries of bioscience — researching the unknown of human biology, in the brain, the cell and the immune system.
@susannalharris.bsky.social
Helping scientists communicate. Working in biotech VC, living in San Francisco, reading in every available armchair.
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@magdalenaskipper.bsky.social
Editor in Chief of Nature, geneticist, editor, accidental potter. All views my own
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & functional longevity. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@jasonrkelly.bsky.social
co-founder and CEO at Ginkgo Bioworks Former Chair of National Security Commission on Emerging Biotechnology
@maxkozlov.bsky.social
science reporter covering biomedical research at Nature | proudly Ukrainian 🇺🇦 maxkozlov.com signal: mkozlov.01
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@biotechmiller.bsky.social
20+ years in the biotech business. Analyst, portfolio manager, VC, & now doing communications and strategy at Curevo Vaccine. Avid sailor who races. All views are my own. What are you doing with your one wild and precious life? (Mary Oliver)
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.